Haluk Vahaboğlu
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 2%
- Viral Infections and Vectors
- HIV/AIDS drug development and treatment
Papers in
-
- Antibiotic Resistance in Bacteria 35
-
- COVID-19 Clinical Research Studies 8
- Viral Infections and Vectors 4
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Fetiye Kolaylı (15 shared papers)Aynur Karadenizli (11 shared papers)Sibel Gündeş (8 shared papers)Hakan Leblebicioğlu (7 shared papers)Hakan Savlı (3 shared papers)Uğur Özbek (1 shared paper)Patrice Nordmann (2 shared papers)Laurent Poirel (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Journal of Medical Microbiology (5 papers)Journal of Antimicrobial Chemotherapy (5 papers)Annals of Clinical Microbiology and Antimicrobials (5 papers)
- Partner nations
- TürkiyeFranceUnited States
In The Last Decade
Haluk Vahaboğlu
96 papers receiving 3k citations
Peers
Comparison fields: 5 of 102
- Molecular Medicine 1.2k
- Infectious Diseases 776
- Applied Microbiology and Biotechnology 53
- Microbiology 92
- Endocrinology 39
Countries citing papers authored by Haluk Vahaboğlu
This map shows the geographic impact of Haluk Vahaboğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haluk Vahaboğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haluk Vahaboğlu more than expected).
Fields of papers citing papers by Haluk Vahaboğlu
This network shows the impact of papers produced by Haluk Vahaboğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haluk Vahaboğlu. The network helps show where Haluk Vahaboğlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Haluk Vahaboğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 287 | |
| 2 | 1997 | 211 | |
| 3 | 1998 | 195 | |
| 4 | 2005 | 180 | |
| 5 | 1999 | 133 | |
| 6 | 2005 | 109 | |
| 7 | 1999 | 105 | |
| 8 | 2011 | 92 | |
| 9 | 2009 | 77 | |
| 10 | 1995 | 75 | |
| 11 | 2001 | 66 | |
| 12 | 2015 | 64 | |
| 13 | 2006 | 60 | |
| 14 | 2016 | 60 | |
| 15 | 2010 | 59 | |
| 16 | 2020 | 59 | |
| 17 | 1996 | 58 | |
| 18 | 2015 | 57 | |
| 19 | 2003 | 56 | |
| 20 | PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. | 2004 | 53 |
About Haluk Vahaboğlu
Haluk Vahaboğlu is a scholar working on Molecular Medicine, Infectious Diseases, Epidemiology, Microbiology and Surgery, having authored 106 papers that have together received 3.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), COVID-19 Clinical Research Studies (8 papers), Infectious Diseases and Tuberculosis (8 papers), Bacterial Infections and Vaccines (5 papers), Viral Infections and Vectors (4 papers), Urinary Tract Infections Management (4 papers), Bacillus and Francisella bacterial research (3 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Infectious Diseases (776 citations), Applied Microbiology and Biotechnology (53 citations), Microbiology (92 citations) and Endocrinology (39 citations). Haluk Vahaboğlu has collaborated with scholars based in Türkiye, France and United States. Frequent co-authors include Fetiye Kolaylı, Aynur Karadenizli, Sibel Gündeş, Hakan Leblebicioğlu, Hakan Savlı, Uğur Özbek, Patrice Nordmann, Laurent Poirel, Recep Öztürk and Hürrem Bodur. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Journal of Medical Microbiology, Journal of Antimicrobial Chemotherapy and Annals of Clinical Microbiology and Antimicrobials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.